Determining the optimal second-line approach in patients with metastatic clear cell renal cell carcinoma (ccRCC) who have progressed either on 1 or 2 lines of therapy and who had ...

SinoMab (03681.HK) Achieves Approximately 43.3% Year-over-Year Decrease in Annual Losses for 2025, Marking Significant Progress in Pipeline Advancement ...

The American Veterinary Medical Association’s Professional Liability Insurance Trust evaluates reported incidents involving ...

Here is a sneak peek at this week’s headlines. Happy Monday, dvm360 readers! We hope that you had an amazing first weekend of ...

The name might sound like a Nordic god, but it is actually the molecular machinery that allows many different species to eat ...

Breast cancer remains one of the most prevalent malignancies worldwide, with approximately 2.3 million new cases diagnosed annually. Cytokines - small ...